Are you a TMBeliever? Mutations and atezolizumab response in solid tumor Editorial


Authors: Maron, S. B.; Klempner, S. J.
Title: Are you a TMBeliever? Mutations and atezolizumab response in solid tumor
Abstract: SUMMARY: Optimizing the utility of tumor mutational burden in solid tumors remains an unmet need and a clinical knowledge gap. Using a centrally determined cutoff of ≥16 mut/Mb, Friedman and colleagues demonstrate an ability to enrich for atezolizumab response in a pretreated pan-cancer multibasket study. See related article by Friedman et al., p. 654 (4). ©2022 American Association for Cancer Research.
Journal Title: Cancer Discovery
Volume: 12
Issue: 3
ISSN: 2159-8274
Publisher: American Association for Cancer Research  
Date Published: 2022-03-01
Start Page: 602
End Page: 603
Language: English
DOI: 10.1158/2159-8290.Cd-21-1642
PUBMED: 35257152
PROVIDER: scopus
DOI/URL:
Notes: Editorial -- Export Date: 1 April 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven Maron
    108 Maron